The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
about
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitorsEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabCombining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCA biological staging model for operable non-small cell lung cancerModeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expressionTrying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma.Molecular events in bronchogenic carcinoma and their implications for therapy.AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical featuresA translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.Adjuvant therapy in completely resected non-small-cell lung cancer.Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancerEpidermal growth factor receptor (EGFR) in lung cancer: an overview and update.Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis.Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patientsSelective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma.Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis.Molecular diagnostics of non-small cell lung cancer using mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration.Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer.COX-2/EGFR expression and survival among women with adenocarcinoma of the lung.Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients w-216G/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma.Type I insulin-like growth factor receptor induces pulmonary tumorigenesis.Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature.Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer.The role of epidermal growth factor receptor in cancer metastasis and microenvironment.The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance?Epidermal growth factor receptor signaling in nonsmall cell lung cancer.Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor.Establishment of a human non-small cell lung cancer cell line resistant to gefitinib.
P2860
Q24644787-D2A7D368-8826-432A-9C1F-B9831D513E13Q24652337-64D99966-8842-48D8-A2E3-40FDD2CC5AE1Q26852202-43E6D316-1D10-4068-8C35-B8AADA65867BQ28367155-DEF655FC-E095-4A9B-964B-7C455B8A836CQ28484612-36162819-FF50-4E54-BCF4-7C22E5E07ADEQ33341178-A340CE00-E1B8-4537-A984-B136724943CEQ33631730-B0D6B71E-1165-400B-8016-D85B68ACE866Q33829241-9D10CBD0-FED4-48C2-BF1A-BB43F39B4965Q33844244-6C32D55F-25F4-43C8-9C86-17BC4D1DF04DQ34083790-EE2F8D6F-F6A9-49A5-BDC4-9DED2CBFE365Q34712741-07163C4A-E149-43A8-9797-730A52F6F24EQ34733314-FF07F86A-F463-4E74-9DA9-B470A8772E48Q35142848-6CF112AE-5857-47C1-AACB-92955597D70DQ35167923-DD3391F5-13A4-4451-8C99-FDEE9C33643BQ35667627-9B6A3C14-8393-4129-92F7-E88BF107622CQ35894555-66678450-5E5D-4F62-9837-8FDAD93783FBQ35926926-EF15FF01-C02E-4C34-BC88-96264BE8622EQ35979157-90405E20-C033-4CF2-BB27-D7C3E1956B45Q36114819-4E4DF33A-3B12-4E4E-A2C5-E036D9E29F40Q36135626-63F071B9-A15F-4ED8-99C5-0E1EF4381F13Q36293820-B23D2BA4-7894-4278-9EBF-15CF1BB311D0Q36311791-D3DBD9B1-5978-411D-8A0A-E086C2B0D149Q36370600-92DA3FE2-934E-4FE5-9763-B35CD4A0F43BQ36772562-EE8F7A10-6E40-4843-ABD4-DEA804B8610FQ36857560-A789ACC6-1504-4107-B2E5-D5EE9F14976EQ37051227-F341C9E8-8331-4071-861E-3DF129C7EE06Q37123936-7769466B-F39E-4BF4-8DE4-6C79DD73AAA7Q37211807-2A289C7F-BE74-46B2-865E-DEB702638B28Q37229930-E25A66B9-4379-4B5A-8893-97CE1FC5EBA2Q37248489-6377656E-7C0C-4996-B0DE-AB21090F784FQ37444619-F3599AA5-25E2-44B3-89D6-9BA123A5AA9DQ37481363-905C7D64-6B0D-4D06-A85B-A9598F208AC8Q37645161-D360ABB6-AFF3-44AB-B188-8FEF99ACC51AQ38132400-42859F71-E997-4BA5-9694-C0B446935372Q38903548-02F52C2A-2148-4934-AF4F-8D4174D74AEEQ38980474-44849C13-D37D-416C-BF75-E30FEAC388D8Q39460393-C561E51B-CE10-4586-8869-36EF0ACB040CQ39752055-CBBE1574-1DD4-4088-A37B-9FDB161774A0Q40031313-E5E3818D-5EFA-49D7-93E6-4935456BCD08Q40447861-C5FBA35A-5DC2-4A0D-8157-5C9700E29BD3
P2860
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The relationship of quantitati ...... g cancer to long term survival
@ast
The relationship of quantitati ...... g cancer to long term survival
@en
type
label
The relationship of quantitati ...... g cancer to long term survival
@ast
The relationship of quantitati ...... g cancer to long term survival
@en
prefLabel
The relationship of quantitati ...... g cancer to long term survival
@ast
The relationship of quantitati ...... g cancer to long term survival
@en
P2093
P2860
P356
P1476
The relationship of quantitati ...... g cancer to long term survival
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.306
P407
P577
1993-07-01T00:00:00Z
P5875
P6179
1004024201